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Background
According to ILAR classification, JIA is classified into 7
different categories based on similar characteristic fea-
tures of each.
Aim
In this study we aimed to investigate whether ANA
positive patients in different ILAR categories constitute
a homogenous group.
Methods
In this cross-sectional study, patients who had been fol-
lowed up for at least a 6 month-period were recruited
from different centers and registered thorough a web-
based registry. Patients were grouped according to their
ANA positivity. Clinical and demographic features were
compared between ANA positive and negative groups.
The results were explored by univariate and multivariate
regression analysis (OR, %95 CI).
Results
A total number of 402 JIA patients of which 169 ANA
positive and 233 ANA negative were enrolled in the
study. The mean age of the diagnosis in ANA negative
and positive groups were 4.65 ± 3.48 and 4.01 ± 2.86
respectively; and female-male ratio for ANA negative
and positive groups were 1.3 (135/98) and 4.1 (136/33)
respectively. The subgroups of the patients according to
ILAR classification system are listed in the table.
According to our results of multipl regression analysis,
the variables which demonstrated statisticly significant
association with ANA presence were female sex (OR
=3.763 (2.26-6.27)), uveitis (OR=5.58 (2.21-14.10)), rheu-
matoid factor positivity (OR=4.07 (1.34-12.36)), high
levels of ESR (OR 0.993 (0.985-1.00)) and small joint
involvement (OR 0.57 (0.31-1.03)).
Conclusion
Our results indicate that, ANA positive patients classi-
fied in different groups by using current ILAR classifica-
tion system, demonstrate similar clinical and laboratory
findings. Thus we suggest that ANA status may be used
as a parameter for classification of JIA.
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Table 1
ANA negative ANA pozitive P
n%n%
Oligoarticular persistent 113 48,5 121 71,6 <0,001
Oligoarticular extended 11 4,7 15 8,9
Polyarticular RF (-) 99 42,5 30 17,8
Psoriatic 10 4,3 3 1,8
Total 233 100 169 100
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